 | • レポートコード：MRC2-11QY04514 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はリウマチ性心臓病のグローバル市場について調査・分析したレポートです。種類別（弁、心筋炎、心膜炎）市場規模、用途別（病院、診断センター、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別リウマチ性心臓病の競争状況、市場シェア ・世界のリウマチ性心臓病市場：種類別市場規模 2015年-2020年（弁、心筋炎、心膜炎） ・世界のリウマチ性心臓病市場：種類別市場規模予測 2021年-2026年（弁、心筋炎、心膜炎） ・世界のリウマチ性心臓病市場：用途別市場規模 2015年-2020年（病院、診断センター、研究センター） ・世界のリウマチ性心臓病市場：用途別市場規模予測 2021年-2026年（病院、診断センター、研究センター） ・北米のリウマチ性心臓病市場分析：米国、カナダ ・ヨーロッパのリウマチ性心臓病市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのリウマチ性心臓病市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のリウマチ性心臓病市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのリウマチ性心臓病市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Bayer、BIOTRONIK、Boston Scientific、Bristol-Myers Squibb、C. R. Bard、Cardinal Health、Cook Medical、Roche、GE Healthcare、InterValve、Novartis、On-X Life Technologies、Osypka Medical、Otsuka、PerkinElmer、Pfizer、Reckitt Benckiser、Siemens Healthineers、Toray ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Rheumatic heart disease is a complication ofrheumatic fever in which the heart valves are damaged.
Increasing environmental pollution resulting in higher prevalence of viral and fungal infection is one of the major factor motivating the growth of this market. In addition, increasing healthcare expenditure by government to tackle rising prevalence of cardiovascular disease is another motivating factor for the market.
Market Analysis and Insights: Global Rheumatic Heart Disease Market
The global Rheumatic Heart Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Rheumatic Heart Disease Scope and Market Size
Rheumatic Heart Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rheumatic Heart Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Bayer
BIOTRONIK
Boston Scientific
Bristol-Myers Squibb
C. R. Bard
Cardinal Health
Cook Medical
Roche
GE Healthcare
InterValve
Novartis
On-X Life Technologies
Osypka Medical
Otsuka
PerkinElmer
Pfizer
Reckitt Benckiser
Siemens Healthineers
Toray
Market segment by Type, the product can be split into
Valve
Myocarditis
Pericarditis
Market segment by Application, split into
Hospital
Diagnostic Centre
Research Centre
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Rheumatic Heart Disease Revenue
1.4 Market by Type
1.4.1 Global Rheumatic Heart Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Valve
1.4.3 Myocarditis
1.4.4 Pericarditis
1.5 Market by Application
1.5.1 Global Rheumatic Heart Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Diagnostic Centre
1.5.4 Research Centre
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Rheumatic Heart Disease Market Perspective (2015-2026)
2.2 Global Rheumatic Heart Disease Growth Trends by Regions
2.2.1 Rheumatic Heart Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Rheumatic Heart Disease Historic Market Share by Regions (2015-2020)
2.2.3 Rheumatic Heart Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Rheumatic Heart Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Rheumatic Heart Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Rheumatic Heart Disease Players by Market Size
3.1.1 Global Top Rheumatic Heart Disease Players by Revenue (2015-2020)
3.1.2 Global Rheumatic Heart Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Rheumatic Heart Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Rheumatic Heart Disease Market Concentration Ratio
3.2.1 Global Rheumatic Heart Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Rheumatic Heart Disease Revenue in 2019
3.3 Rheumatic Heart Disease Key Players Head office and Area Served
3.4 Key Players Rheumatic Heart Disease Product Solution and Service
3.5 Date of Enter into Rheumatic Heart Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Rheumatic Heart Disease Historic Market Size by Type (2015-2020)
4.2 Global Rheumatic Heart Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Rheumatic Heart Disease Market Size by Application (2015-2020)
5.2 Global Rheumatic Heart Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Rheumatic Heart Disease Market Size (2015-2020)
6.2 Rheumatic Heart Disease Key Players in North America (2019-2020)
6.3 North America Rheumatic Heart Disease Market Size by Type (2015-2020)
6.4 North America Rheumatic Heart Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Rheumatic Heart Disease Market Size (2015-2020)
7.2 Rheumatic Heart Disease Key Players in Europe (2019-2020)
7.3 Europe Rheumatic Heart Disease Market Size by Type (2015-2020)
7.4 Europe Rheumatic Heart Disease Market Size by Application (2015-2020)
8 China
8.1 China Rheumatic Heart Disease Market Size (2015-2020)
8.2 Rheumatic Heart Disease Key Players in China (2019-2020)
8.3 China Rheumatic Heart Disease Market Size by Type (2015-2020)
8.4 China Rheumatic Heart Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Rheumatic Heart Disease Market Size (2015-2020)
9.2 Rheumatic Heart Disease Key Players in Japan (2019-2020)
9.3 Japan Rheumatic Heart Disease Market Size by Type (2015-2020)
9.4 Japan Rheumatic Heart Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Rheumatic Heart Disease Market Size (2015-2020)
10.2 Rheumatic Heart Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Rheumatic Heart Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Rheumatic Heart Disease Market Size by Application (2015-2020)
11 India
11.1 India Rheumatic Heart Disease Market Size (2015-2020)
11.2 Rheumatic Heart Disease Key Players in India (2019-2020)
11.3 India Rheumatic Heart Disease Market Size by Type (2015-2020)
11.4 India Rheumatic Heart Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Rheumatic Heart Disease Market Size (2015-2020)
12.2 Rheumatic Heart Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Rheumatic Heart Disease Market Size by Type (2015-2020)
12.4 Central & South America Rheumatic Heart Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Rheumatic Heart Disease Introduction
13.1.4 Abbott Laboratories Revenue in Rheumatic Heart Disease Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Rheumatic Heart Disease Introduction
13.2.4 Bayer Revenue in Rheumatic Heart Disease Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 BIOTRONIK
13.3.1 BIOTRONIK Company Details
13.3.2 BIOTRONIK Business Overview
13.3.3 BIOTRONIK Rheumatic Heart Disease Introduction
13.3.4 BIOTRONIK Revenue in Rheumatic Heart Disease Business (2015-2020)
13.3.5 BIOTRONIK Recent Development
13.4 Boston Scientific
13.4.1 Boston Scientific Company Details
13.4.2 Boston Scientific Business Overview
13.4.3 Boston Scientific Rheumatic Heart Disease Introduction
13.4.4 Boston Scientific Revenue in Rheumatic Heart Disease Business (2015-2020)
13.4.5 Boston Scientific Recent Development
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Details
13.5.2 Bristol-Myers Squibb Business Overview
13.5.3 Bristol-Myers Squibb Rheumatic Heart Disease Introduction
13.5.4 Bristol-Myers Squibb Revenue in Rheumatic Heart Disease Business (2015-2020)
13.5.5 Bristol-Myers Squibb Recent Development
13.6 C. R. Bard
13.6.1 C. R. Bard Company Details
13.6.2 C. R. Bard Business Overview
13.6.3 C. R. Bard Rheumatic Heart Disease Introduction
13.6.4 C. R. Bard Revenue in Rheumatic Heart Disease Business (2015-2020)
13.6.5 C. R. Bard Recent Development
13.7 Cardinal Health
13.7.1 Cardinal Health Company Details
13.7.2 Cardinal Health Business Overview
13.7.3 Cardinal Health Rheumatic Heart Disease Introduction
13.7.4 Cardinal Health Revenue in Rheumatic Heart Disease Business (2015-2020)
13.7.5 Cardinal Health Recent Development
13.8 Cook Medical
13.8.1 Cook Medical Company Details
13.8.2 Cook Medical Business Overview
13.8.3 Cook Medical Rheumatic Heart Disease Introduction
13.8.4 Cook Medical Revenue in Rheumatic Heart Disease Business (2015-2020)
13.8.5 Cook Medical Recent Development
13.9 Roche
13.9.1 Roche Company Details
13.9.2 Roche Business Overview
13.9.3 Roche Rheumatic Heart Disease Introduction
13.9.4 Roche Revenue in Rheumatic Heart Disease Business (2015-2020)
13.9.5 Roche Recent Development
13.10 GE Healthcare
13.10.1 GE Healthcare Company Details
13.10.2 GE Healthcare Business Overview
13.10.3 GE Healthcare Rheumatic Heart Disease Introduction
13.10.4 GE Healthcare Revenue in Rheumatic Heart Disease Business (2015-2020)
13.10.5 GE Healthcare Recent Development
13.11 InterValve
10.11.1 InterValve Company Details
10.11.2 InterValve Business Overview
10.11.3 InterValve Rheumatic Heart Disease Introduction
10.11.4 InterValve Revenue in Rheumatic Heart Disease Business (2015-2020)
10.11.5 InterValve Recent Development
13.12 Novartis
10.12.1 Novartis Company Details
10.12.2 Novartis Business Overview
10.12.3 Novartis Rheumatic Heart Disease Introduction
10.12.4 Novartis Revenue in Rheumatic Heart Disease Business (2015-2020)
10.12.5 Novartis Recent Development
13.13 On-X Life Technologies
10.13.1 On-X Life Technologies Company Details
10.13.2 On-X Life Technologies Business Overview
10.13.3 On-X Life Technologies Rheumatic Heart Disease Introduction
10.13.4 On-X Life Technologies Revenue in Rheumatic Heart Disease Business (2015-2020)
10.13.5 On-X Life Technologies Recent Development
13.14 Osypka Medical
10.14.1 Osypka Medical Company Details
10.14.2 Osypka Medical Business Overview
10.14.3 Osypka Medical Rheumatic Heart Disease Introduction
10.14.4 Osypka Medical Revenue in Rheumatic Heart Disease Business (2015-2020)
10.14.5 Osypka Medical Recent Development
13.15 Otsuka
10.15.1 Otsuka Company Details
10.15.2 Otsuka Business Overview
10.15.3 Otsuka Rheumatic Heart Disease Introduction
10.15.4 Otsuka Revenue in Rheumatic Heart Disease Business (2015-2020)
10.15.5 Otsuka Recent Development
13.16 PerkinElmer
10.16.1 PerkinElmer Company Details
10.16.2 PerkinElmer Business Overview
10.16.3 PerkinElmer Rheumatic Heart Disease Introduction
10.16.4 PerkinElmer Revenue in Rheumatic Heart Disease Business (2015-2020)
10.16.5 PerkinElmer Recent Development
13.17 Pfizer
10.17.1 Pfizer Company Details
10.17.2 Pfizer Business Overview
10.17.3 Pfizer Rheumatic Heart Disease Introduction
10.17.4 Pfizer Revenue in Rheumatic Heart Disease Business (2015-2020)
10.17.5 Pfizer Recent Development
13.18 Reckitt Benckiser
10.18.1 Reckitt Benckiser Company Details
10.18.2 Reckitt Benckiser Business Overview
10.18.3 Reckitt Benckiser Rheumatic Heart Disease Introduction
10.18.4 Reckitt Benckiser Revenue in Rheumatic Heart Disease Business (2015-2020)
10.18.5 Reckitt Benckiser Recent Development
13.19 Siemens Healthineers
10.19.1 Siemens Healthineers Company Details
10.19.2 Siemens Healthineers Business Overview
10.19.3 Siemens Healthineers Rheumatic Heart Disease Introduction
10.19.4 Siemens Healthineers Revenue in Rheumatic Heart Disease Business (2015-2020)
10.19.5 Siemens Healthineers Recent Development
13.20 Toray
10.20.1 Toray Company Details
10.20.2 Toray Business Overview
10.20.3 Toray Rheumatic Heart Disease Introduction
10.20.4 Toray Revenue in Rheumatic Heart Disease Business (2015-2020)
10.20.5 Toray Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Rheumatic Heart Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Rheumatic Heart Disease Revenue
Table 3. Ranking of Global Top Rheumatic Heart Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Rheumatic Heart Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Valve
Table 6. Key Players of Myocarditis
Table 7. Key Players of Pericarditis
Table 8. Global Rheumatic Heart Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Rheumatic Heart Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Rheumatic Heart Disease Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Rheumatic Heart Disease Market Share by Regions (2015-2020)
Table 12. Global Rheumatic Heart Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Rheumatic Heart Disease Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Rheumatic Heart Disease Market Growth Strategy
Table 18. Main Points Interviewed from Key Rheumatic Heart Disease Players
Table 19. Global Rheumatic Heart Disease Revenue by Players (2015-2020) (Million US$)
Table 20. Global Rheumatic Heart Disease Market Share by Players (2015-2020)
Table 21. Global Top Rheumatic Heart Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatic Heart Disease as of 2019)
Table 22. Global Rheumatic Heart Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Rheumatic Heart Disease Product Solution and Service
Table 25. Date of Enter into Rheumatic Heart Disease Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rheumatic Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 28. Global Rheumatic Heart Disease Market Size Share by Type (2015-2020)
Table 29. Global Rheumatic Heart Disease Revenue Market Share by Type (2021-2026)
Table 30. Global Rheumatic Heart Disease Market Size Share by Application (2015-2020)
Table 31. Global Rheumatic Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 32. Global Rheumatic Heart Disease Market Size Share by Application (2021-2026)
Table 33. North America Key Players Rheumatic Heart Disease Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Rheumatic Heart Disease Market Share (2019-2020)
Table 35. North America Rheumatic Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 36. North America Rheumatic Heart Disease Market Share by Type (2015-2020)
Table 37. North America Rheumatic Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 38. North America Rheumatic Heart Disease Market Share by Application (2015-2020)
Table 39. Europe Key Players Rheumatic Heart Disease Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Rheumatic Heart Disease Market Share (2019-2020)
Table 41. Europe Rheumatic Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Rheumatic Heart Disease Market Share by Type (2015-2020)
Table 43. Europe Rheumatic Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Rheumatic Heart Disease Market Share by Application (2015-2020)
Table 45. China Key Players Rheumatic Heart Disease Revenue (2019-2020) (Million US$)
Table 46. China Key Players Rheumatic Heart Disease Market Share (2019-2020)
Table 47. China Rheumatic Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 48. China Rheumatic Heart Disease Market Share by Type (2015-2020)
Table 49. China Rheumatic Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 50. China Rheumatic Heart Disease Market Share by Application (2015-2020)
Table 51. Japan Key Players Rheumatic Heart Disease Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Rheumatic Heart Disease Market Share (2019-2020)
Table 53. Japan Rheumatic Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Rheumatic Heart Disease Market Share by Type (2015-2020)
Table 55. Japan Rheumatic Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Rheumatic Heart Disease Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Rheumatic Heart Disease Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Rheumatic Heart Disease Market Share (2019-2020)
Table 59. Southeast Asia Rheumatic Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Rheumatic Heart Disease Market Share by Type (2015-2020)
Table 61. Southeast Asia Rheumatic Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Rheumatic Heart Disease Market Share by Application (2015-2020)
Table 63. India Key Players Rheumatic Heart Disease Revenue (2019-2020) (Million US$)
Table 64. India Key Players Rheumatic Heart Disease Market Share (2019-2020)
Table 65. India Rheumatic Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 66. India Rheumatic Heart Disease Market Share by Type (2015-2020)
Table 67. India Rheumatic Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 68. India Rheumatic Heart Disease Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Rheumatic Heart Disease Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Rheumatic Heart Disease Market Share (2019-2020)
Table 71. Central & South America Rheumatic Heart Disease Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Rheumatic Heart Disease Market Share by Type (2015-2020)
Table 73. Central & South America Rheumatic Heart Disease Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Rheumatic Heart Disease Market Share by Application (2015-2020)
Table 75. Abbott Laboratories Company Details
Table 76. Abbott Laboratories Business Overview
Table 77. Abbott Laboratories Product
Table 78. Abbott Laboratories Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 79. Abbott Laboratories Recent Development
Table 80. Bayer Company Details
Table 81. Bayer Business Overview
Table 82. Bayer Product
Table 83. Bayer Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 84. Bayer Recent Development
Table 85. BIOTRONIK Company Details
Table 86. BIOTRONIK Business Overview
Table 87. BIOTRONIK Product
Table 88. BIOTRONIK Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 89. BIOTRONIK Recent Development
Table 90. Boston Scientific Company Details
Table 91. Boston Scientific Business Overview
Table 92. Boston Scientific Product
Table 93. Boston Scientific Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 94. Boston Scientific Recent Development
Table 95. Bristol-Myers Squibb Company Details
Table 96. Bristol-Myers Squibb Business Overview
Table 97. Bristol-Myers Squibb Product
Table 98. Bristol-Myers Squibb Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 99. Bristol-Myers Squibb Recent Development
Table 100. C. R. Bard Company Details
Table 101. C. R. Bard Business Overview
Table 102. C. R. Bard Product
Table 103. C. R. Bard Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 104. C. R. Bard Recent Development
Table 105. Cardinal Health Company Details
Table 106. Cardinal Health Business Overview
Table 107. Cardinal Health Product
Table 108. Cardinal Health Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 109. Cardinal Health Recent Development
Table 110. Cook Medical Business Overview
Table 111. Cook Medical Product
Table 112. Cook Medical Company Details
Table 113. Cook Medical Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 114. Cook Medical Recent Development
Table 115. Roche Company Details
Table 116. Roche Business Overview
Table 117. Roche Product
Table 118. Roche Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 119. Roche Recent Development
Table 120. GE Healthcare Company Details
Table 121. GE Healthcare Business Overview
Table 122. GE Healthcare Product
Table 123. GE Healthcare Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 124. GE Healthcare Recent Development
Table 125. InterValve Company Details
Table 126. InterValve Business Overview
Table 127. InterValve Product
Table 128. InterValve Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 129. InterValve Recent Development
Table 130. Novartis Company Details
Table 131. Novartis Business Overview
Table 132. Novartis Product
Table 133. Novartis Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 134. Novartis Recent Development
Table 135. On-X Life Technologies Company Details
Table 136. On-X Life Technologies Business Overview
Table 137. On-X Life Technologies Product
Table 138. On-X Life Technologies Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 139. On-X Life Technologies Recent Development
Table 140. Osypka Medical Company Details
Table 141. Osypka Medical Business Overview
Table 142. Osypka Medical Product
Table 143. Osypka Medical Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 144. Osypka Medical Recent Development
Table 145. Otsuka Company Details
Table 146. Otsuka Business Overview
Table 147. Otsuka Product
Table 148. Otsuka Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 149. Otsuka Recent Development
Table 150. PerkinElmer Company Details
Table 151. PerkinElmer Business Overview
Table 152. PerkinElmer Product
Table 153. PerkinElmer Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 154. PerkinElmer Recent Development
Table 155. Pfizer Company Details
Table 156. Pfizer Business Overview
Table 157. Pfizer Product
Table 158. Pfizer Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 159. Pfizer Recent Development
Table 160. Reckitt Benckiser Company Details
Table 161. Reckitt Benckiser Business Overview
Table 162. Reckitt Benckiser Product
Table 163. Reckitt Benckiser Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 164. Reckitt Benckiser Recent Development
Table 165. Siemens Healthineers Company Details
Table 166. Siemens Healthineers Business Overview
Table 167. Siemens Healthineers Product
Table 168. Siemens Healthineers Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 169. Siemens Healthineers Recent Development
Table 170. Toray Company Details
Table 171. Toray Business Overview
Table 172. Toray Product
Table 173. Toray Revenue in Rheumatic Heart Disease Business (2015-2020) (Million US$)
Table 174. Toray Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rheumatic Heart Disease Market Share by Type: 2020 VS 2026
Figure 2. Valve Features
Figure 3. Myocarditis Features
Figure 4. Pericarditis Features
Figure 5. Global Rheumatic Heart Disease Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Diagnostic Centre Case Studies
Figure 8. Research Centre Case Studies
Figure 9. Rheumatic Heart Disease Report Years Considered
Figure 10. Global Rheumatic Heart Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Rheumatic Heart Disease Market Share by Regions: 2020 VS 2026
Figure 12. Global Rheumatic Heart Disease Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Rheumatic Heart Disease Market Share by Players in 2019
Figure 15. Global Top Rheumatic Heart Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatic Heart Disease as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Rheumatic Heart Disease Revenue in 2019
Figure 17. North America Rheumatic Heart Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Rheumatic Heart Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Rheumatic Heart Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Rheumatic Heart Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Rheumatic Heart Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Rheumatic Heart Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Rheumatic Heart Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
炎症性心疾患の世界市場（～2026年） Inflammatory heart disease is mainly caused by various infectious agents which includes viruses, bacteria, fungi and parasites. These infectious agents came into contact with human body via various toxic materials from the environment. Changing lifestyle resulting in higher prevalence of viral and f…- 先天性心疾患の世界市場（～2026年） A congenital heart disease is a problem in the structure of the heart that is present at birth. The factors driving the growth of the global congenital heart disease market are rising prevalence of congenital heart disease and rise in adoption of minimally invasive procedures. Further, large number …
- リウマチ熱治療の世界市場（～2026年） Rheumatic fever is an autoimmune inflammatory disease which can develop as a complication of inadequately treated strep throat. Strep throat is a condition caused by group a Streptococcus bacterium. Rheumatic fever is common in the age group of 5 to 15 years, but adults can also have the condition. …
- 虚血性心疾患（IHD）薬の世界市場（～2026年） Ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. It is within the group of cardiovascular diseases of which it is the most common type. A common symptom is chest pain or discomfort which may tr…
- 人工心臓弁/人工心臓弁の世界市場（～2026年） Market Analysis and Insights: Global Prosthetic Heart Valve/ Artificial Heart Valve Market The global Prosthetic Heart Valve/ Artificial Heart Valve market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prosthetic Heart Valv…